YouTube Facebook LinkedIn Google+ Twitter Xingrss  


Genomic Prostate Cancer Test Gauges Tumor Aggressiveness



May 9, 2013 | A new genetic test—Oncotype DX Genomic Prostate Score—purports to gauge the aggressiveness of prostate cancer, helping doctors and patients decide if they should their cancer right away or can safely monitor it. The test, and another one recently on the market, analyzes genes in a biopsy sample and gives a score for aggressiveness. Boston Herald
Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.